Phase 3 trials are still running, and Eli Lilly is expected to submit retatrutide for regulatory approval once the remaining trials report results across 2026
Animal studies, particularly in rodents, have shown that high-dose GLP-1 exposure can lead to pancreatic ductal proliferation and, in some cases, inflammatory changes
Tirzepatide is only FDA approved for treatment of diabetes
On a different level, GLP-1RAs reduce the concentration of angiotensin II (Ang II), which lowers arterial hypertension in T2DM and improves systemic insulin sensitivity ( 4.3 Gastrointestinal effects The gastrointestinal (GI) tract is greatly impacted by GLP-1RAs
GLP-1 users are shifting to smaller pack sizes at higher rates than average US consumers in all of Big Chalks bellwether categories, which is not surprising, Miller said
Just fixing something that wasnt working properly initially